Insider Profile
Larente, André
$ADK
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Jun 11, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Jun 11, 2026 $ADK
Diagnos Inc.
— Comp. Grant Buy 300,000 $0.20 $60K 73
Feb 24, 2026 $ADK
Diagnos Inc.
— Expiry Sell 1,200,000 — — 73
Dec 05, 2025 $ADK
Diagnos Inc.
— Open Market Sell 83,333 $0.30 $25K 73
Dec 05, 2025 $ADK
Diagnos Inc.
— Open Market Sell 83,333 — — 73
Sep 25, 2025 $ADK
Diagnos Inc.
— Comp. Grant Buy 600,000 $0.26 $156K 73
Aug 26, 2025 $ADK
Diagnos Inc.
— Expiry Sell 600,000 — — 73
Mar 01, 2025 $ADK
Diagnos Inc.
— Other Sell — — — 73
Oct 03, 2024 $ADK
Diagnos Inc.
— Comp. Grant Buy 600,000 $0.37 $222K 73
Sep 25, 2024 $ADK
Diagnos Inc.
— Expiry Sell 600,000 — — 73
Jan 28, 2024 $ADK
Diagnos Inc.
— Expiry Sell 60,000 $0.50 $30K 73
Aug 29, 2023 $ADK
Diagnos Inc.
— Exercise Buy 5,000 $0.33 $2K 73
Aug 29, 2023 $ADK
Diagnos Inc.
— Exercise Sell 5,000 — — 73
May 28, 2023 $ADK
Diagnos Inc.
— Expiry Sell 50,000 — — 73
Feb 10, 2023 $ADK
Diagnos Inc.
— Comp. Grant Buy 150,000 $0.42 $64K 73
Mar 01, 2022 $ADK
Diagnos Inc.
— Comp. Grant Buy 5,000 — — 73
Feb 24, 2021 $ADK
Diagnos Inc.
— Comp. Grant Buy 1,200,000 $0.56 $672K 73
Aug 26, 2020 $ADK
Diagnos Inc.
— Comp. Grant Buy 600,000 $0.18 $108K 73
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.